Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...
Explore the depths of retina scan authentication, from its technology and security to ethical considerations and implementation. A guide for developers and security pros.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback